case_images: PMC5656357_01
case_images: Slit-lamp images depicting the status after trabeculectomy and phacoemulsification before the onset of bullous keratopathy. Note the iridocorneal contact at the slit beam (yellow arrow).
case_images: tcrm-13-1443Fig1.jpg
case_images: PMC5656357_01_tcrm-13-1443Fig1.jpg
case_images: f1-tcrm-13-1443
case_images: The postoperative course was complicated by prolonged athalamia (Figure 1) resulting in extensive central iridocorneal synechiae.
case_images: Slit-lamp images depicting the detached Descemet membrane and synechiae at the level of the pupil following descemetorhexis. Note the severe edema due to the absence of corneal endothelium (yellow arrows).
case_images: tcrm-13-1443Fig2.jpg
case_images: PMC5656357_01_tcrm-13-1443Fig2.jpg
case_images: f2-tcrm-13-1443
case_images: Indeed, 1 month later, no synechiae were visible on slit-lamp examination, the anterior chamber was deep, and the contracted, fibrotic DM was occupying the pupil (Figure 2).
case_images: UT-DSAEK performed 3 months after descemetorhexis for removal of anterior synechiae allowed the restoration of corneal clarity. Note the fibrotic and wrinkled membrane at the level of the pupil consisting of detached Descemet membrane and iridocorneal tissue (yellow arrows).. Abbreviation: UT-DSAEK, ultrathin Descemet stripping endothelial keratoplasty.
case_images: tcrm-13-1443Fig3.jpg
case_images: PMC5656357_01_tcrm-13-1443Fig3.jpg
case_images: f3-tcrm-13-1443
case_images: Two months later, ultrathin Descemet stripping endothelial keratoplasty was performed, allowing restoration of corneal clarity (Figure 3).
case_images: Slit-lamp images depicting the status following vitrectome-assisted removal of the fibrotic membrane at 2 months after UT-DSAEK. The anterior chamber appears clear and the pupil is round in shape.. Abbreviation: UT-DSAEK, ultrathin Descemet stripping endothelial keratoplasty.
case_images: tcrm-13-1443Fig4.jpg
case_images: PMC5656357_01_tcrm-13-1443Fig4.jpg
case_images: f4-tcrm-13-1443
case_images: One month later, BCVA increased to 0.5 (Figure 4) and remained at that level until the last follow-up 1 year later.